Evidence map›Paper›PMID 21699782›Full record

ArticleGastroenterology2011

Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice.

Daniel P Poole, Juan-Carlos Pelayo, Gregory Scherrer, Christopher J Evans, Brigitte L Kieffer, Nigel W Bunnett

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2022
    Review
  8. Mice expressing fluorescent PARProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Inflammation-associated changes in DOR expression and function in the mouse colon.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Daniel P Poole *Department of Surgery, University of California, San Francisco.
Juan-Carlos Pelayo *Department of Surgery, University of California, San Francisco.
Gregory ScherrerDepartment of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032.
Christopher J EvansShirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles.
Brigitte L KiefferDépartement de Neurobiologie, Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM U596, CNRS UMR7104, Université Louis Pasteur, Illkirch, France.
Nigel W BunnettDepartment of Surgery, University of California, San Francisco.
University of California, San Francisco · USColumbia University · USInserm · FRUniversity of California, Los Angeles · US

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIANGDONG WILLIAM · 1987 to 2021
$30.7M
REGULATION OF CELLULAR RESPONSES TO NEUROPEPTIDESR37DK039957 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2000 to 2010
$3.2M
RESEARCH TRAINING IN GASTROINTESTINAL SURGERYT32DK007573 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HARRIS, HOBART WHITAKER · 1988 to 2019
$3.0M
PROTEINASE-ACTIVATED RECEPTORS/PERIPHERAL NERVOUS SYSTEMR01DK057840 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2000 to 2010
$2.2M
REGULATION OF SIGNALING BY CELL SURFACE PROTEOLYSISR01DK043207 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 1993 to 2011
$1.7M
REGULATION OF SIGNALING BY CELL-SURFACE PROTEOLYSISR56DK043207 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2010 to 2010
$348k
REGULATION OF CELLULAR RESPONSES TO NEUROPEPTIDESR01DK039957 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BUNNETT, NIGEL W · 1987 to 1998
–
NIDA NIH HHS DA005010NIDA NIH HHS P50 DA005010NIDDK NIH HHS DK07573NIDDK NIH HHS DK39957NIDDK NIH HHS DK43207NIDDK NIH HHS DK57840NIDDK NIH HHS DK57850NIDDK NIH HHS R01 DK039957NIDDK NIH HHS R01 DK043207NIDDK NIH HHS R37 DK039957NIDDK NIH HHS R56 DK043207NIDDK NIH HHS T32 DK007573
6 · The paper itself

Abstract

BACKGROUND &

aimsOpioids and opiates inhibit gastrointestinal functions via μ, δ, and κ receptors. Although agonists of the δ opioid receptor (DOR) suppress motility and secretion, little is known about the localization and regulation of DOR in the gastrointestinal tract.

methodsWe studied mice in which the gene that encodes the enhanced green fluorescent protein (eGFP) was inserted into Oprd1, which encodes DOR, to express an approximately 80-kilodalton product (DOReGFP). We used these mice to localize DOR and to determine how agonists regulate the subcellular distribution of DOR.

resultsDOReGFP was expressed in all regions but was confined to enteric neurons and fibers within the muscularis externa. In the submucosal plexus, DOReGFP was detected in neuropeptide Y-positive secretomotor and vasodilator neurons of the small intestine, but rarely was observed in the large bowel. In the myenteric plexus of the small intestine, DOReGFP was present in similar proportions of excitatory motoneurons and interneurons that expressed choline acetyltransferase and substance P, and in inhibitory motoneurons and interneurons that contained nitric oxide synthase. DOReGFP was present mostly in nitrergic myenteric neurons of colon. DOReGFP and μ opioid receptors often were co-expressed. DOReGFP-expressing neurons were associated with enkephalin-containing varicosities, and enkephalin-induced clathrin- and dynamin-mediated endocytosis and lysosomal trafficking of DOReGFP. DOReGFP replenishment at the plasma membrane was slow, requiring de novo synthesis, rather than recycling.

conclusionsDOR localizes specifically to submucosal and myenteric neurons, which might account for the ability of DOR agonists to inhibit gastrointestinal secretion and motility. Sustained down-regulation of DOReGFP at the plasma membrane of activated neurons could induce long-lasting tolerance to DOR agonists.

Indexed as

AnimalsCell MembraneEnteric Nervous SystemFemaleGreen Fluorescent ProteinsInterneuronsMaleMiceMice, Inbred StrainsModels, AnimalMotor NeuronsMyenteric PlexusReceptors, Opioid, deltaSubmucous PlexusSubstance PGreen Fluorescent ProteinsReceptors, Opioid, deltaSubstance P

Identifiers

PMID21699782
PMCPMC4429902
OpenAlexW2168070021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.